An angel syndicate headquartered in Baltimore, Maryland. The group invests in device, diagnostics, and digital health companies globally. The group will invest as early as Seed rounds up to Series B. Typical check size falls between $250k-1M USD and prefers to co-invest. The firm will invest through equity or convertible notes.
The firm invests in medical devices, digital health, and diagnostics. The firm does not invest in therapeutics. In terms of devices, the firm is open to all classes of devices. Current interest is in cardiology, structural heart, and neurology, but the firm is indication-agnostic. Although there is preference with earlier stages of development, the firm is stage-agnostic.
The firm may take a board seat on a case-by-case basis. The firm requires companies to have at least one full time executive.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment